What does CUSIP 74449F308 represent in this 13F holders report?

CUSIP 74449F308 is the security identifier for PBM - PSYENCE BIOMEDICAL LTD. - Common Shares used to aggregate holder disclosures.

How many institutions held PBM - PSYENCE BIOMEDICAL LTD. - Common Shares in Q3 2025?

6 institutional investors reported PBM - PSYENCE BIOMEDICAL LTD. - Common Shares for Q3 2025. Use the holders table for investor-level position and value details.

PSYENCE BIOMEDICAL LTD. - Common Shares (PBM)

CUSIP: 74449F308

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / Common Shares
Shares outstanding: 1,022,682
Total 13F shares: 175,354
Share change: +144,721
Total reported value: $763,723
Price per share: $3.20
Number of holders: 6
Value change: +$618,233
Number of buys: 4
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 74449F308?
CUSIP 74449F308 identifies PBM - PSYENCE BIOMEDICAL LTD. - Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2025
Previous quarter: Q2 2025

Recent filing periods for CUSIP 74449F308:

Q4 2025 Q3 2025 Q2 2025

Top shareholders of PBM - PSYENCE BIOMEDICAL LTD. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Parallel Advisors, LLC	13F	Company	— mixed-class rows	325,000 mixed-class rows	$463,015	—	30 Jun 2025	13F
Hudson Bay Capital Management LP	13D/G	—	5%	237,768	$133,150	-$79,650	31 Mar 2025	13D/G
SABBY MANAGEMENT, LLC	13F	Company	2%	20,328	$108,348	—	30 Jun 2025	13F
AdvisorShares Investments LLC	13F	Company	0.43%	4,448	$23,708	—	30 Jun 2025	13F
Harraden Circle Investments, LLC	13F	Company	— class O/S missing	1,150,000	$23,345	—	30 Jun 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.33%	3,340	$17,802	—	30 Jun 2025	13F
AdvisorShares Trust	13D/G	—	0.79%	26,924	$15,077	$0	31 Dec 2024	13D/G
Polar Asset Management Partners Inc.	13F	Company	— class O/S missing	733,000	$14,880	—	30 Jun 2025	13F
MMCAP International Inc. SPC	13F	Company	— class O/S missing	600,000	$12,180	—	30 Jun 2025	13F
UBS Group AG	13F	Company	0.19%	1,956	$10,425	—	30 Jun 2025	13F
TORONTO DOMINION BANK	13F	Company	— class O/S missing	503,212	$10,215	—	30 Jun 2025	13F
Calamos Advisors LLC	13F	Company	— class O/S missing	500,000	$10,100	—	30 Jun 2025	13F
CANTOR FITZGERALD, L. P.	13F	Individual	— class O/S missing	468,500	$9,511	—	30 Jun 2025	13F
Saba Capital Management, L.P.	13F	Company	— class O/S missing	297,847	$6,031	—	30 Jun 2025	13F
ARISTEIA CAPITAL, L.L.C.	13F	Company	— class O/S missing	247,857	$5,019	—	30 Jun 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	200,117	$4,062	—	30 Jun 2025	13F
LMR Partners LLP	13F	Company	— class O/S missing	200,000	$4,060	—	30 Jun 2025	13F
CLEAR STREET LLC	13F	Company	— class O/S missing	180,466	$3,663	—	30 Jun 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	— class O/S missing	175,352	$3,542	—	30 Jun 2025	13F
TENOR CAPITAL MANAGEMENT Co., L.P.	13F	Company	— class O/S missing	150,000	$3,045	—	30 Jun 2025	13F
Stonehage Fleming Financial Services Holdings Ltd	13F	Company	0.05%	561	$2,990	—	30 Jun 2025	13F
WOLVERINE ASSET MANAGEMENT LLC	13F	Company	— class O/S missing	147,101	$2,986	—	30 Jun 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	137,442	$2,776	—	30 Jun 2025	13F
Clear Street Derivatives LLC	13F	Company	— class O/S missing	109,356	$2,220	—	30 Jun 2025	13F
Westchester Capital Management, LLC	13F	Company	— class O/S missing	92,073	$1,860	—	30 Jun 2025	13F
Yakira Capital Management, Inc.	13F	Company	— class O/S missing	76,843	$1,560	—	30 Jun 2025	13F
Mint Tower Capital Management B.V.	13F	Company	— class O/S missing	50,000	$1,000	—	30 Jun 2025	13F
LPL Financial LLC	13F	Company	— class O/S missing	29,345	$596	—	30 Jun 2025	13F
Ancora Advisors LLC	13F	Company	— class O/S missing	5,000	$101	—	30 Jun 2025	13F

Institutional Holders of PSYENCE BIOMEDICAL LTD. - Common Shares (PBM) as of Q3 2025

As of 30 Sep 2025, PSYENCE BIOMEDICAL LTD. - Common Shares (PBM) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 175,354 shares. The largest 6 holders included Parallel Advisors, LLC, Virtu Financial LLC, AdvisorShares Investments LLC, OSAIC HOLDINGS, INC., BANK OF AMERICA CORP /DE/, and Stonehage Fleming Financial Services Holdings Ltd. This page lists 6 institutional shareholders reporting positions in this security for the Q3 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

Q3 2025 holders

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 Value $	Q3 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.